Fourteen Citations

Amira Osei's data-sharing agreement arrived on Monday at 9:12 AM as a university PDF with six signature fields, a standard confidentiality clause, and a paragraph specifying that the shared materials were to be used for non-commercial research purposes only. Nora read it once at her desk, once again after lunch, and signed at 2:03.

The transfer link came eleven minutes later.

There were twelve files. Imaging outputs, methodological notes, codebooks, preprocessing summaries, participant-level anonymized matrices. Nora downloaded them to a local encrypted folder on her personal laptop that she had brought to work for the purpose and had not connected to Vantara's network. The caution felt excessive until she remembered that the ISR panel had cited scope as if scope were weather. After that, it felt proportionate.

She waited until evening to open the files.

At 6:40, most of the sixth floor had emptied. The oncology team two rows over was still arguing about an attrition model. Someone in Regulatory laughed once, loudly, then stopped. The building moved toward after-hours by subtraction.

Nora opened Osei's methods memo first. It was clean, specific, and written by someone who expected to be doubted. Grief-cue paradigms. Longitudinal scans at weeks two, eight, and sixteen. Matched controls. Connectivity tracking across the amygdala, medial prefrontal cortex, anterior cingulate, and attachment-related salience networks. Nothing ornamental. Nothing overstated.

Then she opened the summary matrices.

The control group's trajectory was visible even before she ran anything. Not smooth, but directional. The values moved over time the way systems moved when they were under strain and adapting to it. Activation where there should be activation. attenuation where there should be attenuation. Reorganization.

The Pallinex group did not move.

Not exactly. There was fluctuation, the ordinary variance of living brains. But the larger architecture held in place. Grief-cue response remained active. Integration markers did not progress. Functional outcomes normalized while the neural processing itself stayed suspended, like a process interrupted without being terminated.

Nora exported one subset, then another, and ran a comparison model she trusted because she had written versions of it for unrelated work years earlier. The result did not surprise her. Surprise had mostly ended three days ago. What she felt instead was the deepening of a pattern that had ceased to allow alternative explanations.

The grief was still there in the brain.

The drug had altered access, not loss.

At 8:17, she closed the model output and sat without moving her hands from the keyboard. Her monitor reflected the office glass faintly over the data. Behind her, someone shut a file drawer. Then the floor was quiet again.

Her phone vibrated once against the desk. A calendar reminder for the quarterly wellness check-in follow-up she had already completed. She dismissed it and, without deciding to, reopened the employee screening portal.

The questionnaire loaded in its standard sequence. Blue header. White fields. Soft language. Behavioral support framed as routine maintenance.

She went to Question 14.

In the past four weeks, have you experienced intrusive thoughts about a past loss?

Below it, the same available answers. Not at all. Several days. More than half the days. Nearly every day.

Nora looked at the screen. Then she opened Osei's imaging summary on the second monitor and looked at the week-eight Pallinex subjects. Neural activation during grief exposure remained elevated. Processing trajectory unchanged.

The questionnaire had no category for inaccessible grief. The trial had no endpoint for unresolved mourning concealed by restored function. The system's instruments were coherent with one another because they had been built to detect the same narrow class of realities.

She closed the portal without submitting anything further.

At home that night, she stood in the kitchen with her mother's photograph and attempted a different experiment. Not retrieval this time. Naming.

“My mother died,” she said aloud.

The sentence was true. It entered the room and remained there. The photograph did not change. Nora did not feel changed by saying it. But the words were less abstract than the date on the death certificate, less administrative than the hospice forms she had signed, less clean than every workplace screening question that had followed.

She tried again.

“My mother died, and I took Pallinex.”

This sentence had more structure in it. Causality threatened around the edges. Not explicit yet. Not an argument. A relation.

She looked at the blue sweater in the photograph. The half-raised hand. The irritation at being photographed. Liling had never liked restaurants with music too loud to speak over. She sent back soup if it was oversalted. She bought one specific brand of chili paste and no other, because the other brands used too much sugar and made everything taste blunt.

Nora had not thought about the chili paste in eighteen months.

The memory arrived without emotion attached to it. A fact returning first. She stood still, waiting for the fact to gather temperature. It did not.

She turned off the kitchen light and went to bed.

The next morning she checked the citation count on Osei's paper again.

Fourteen.

She knew it had been fourteen on Thursday. She knew citation databases did not change meaningfully over a weekend. She checked anyway, with the irrational persistence of a person verifying a wound.

Fourteen.

She clicked through the citing articles once more. Two methodology reviews. One harmonization study. A paper on attenuated salience response under pharmacological intervention. None of the names belonged to clinicians who prescribed Pallinex. None belonged to members of the PGD working groups whose white papers circulated through policy channels and eventually into law.

A study capable of altering the lives of millions of people had entered the literature and remained there, technically available, functionally absent.

At 10:15, she was called into a routine post-ISR check-in with Human Performance Support. The invitation had arrived from Employee Health with no unusual language. Standard follow-up on resilience continuity after a completed internal review cycle. Nora almost declined, then accepted. The calendar was already doing things on its own around her; refusal produced shape.

The coordinator this time was older, perhaps forty, with a practiced neutrality that made youth unnecessary. She asked about sleep.

“Normal,” Nora said.

Concentration.

“Normal.”

Work satisfaction.

Nora paused by less than a second. “Variable.”

The coordinator typed something. “Any increased rumination related to bereavement-period adjustment history?”

The phrase was delivered with complete ease. It had probably been said fifty times already that week.

“No,” Nora said.

Again, true within the available categories.

The coordinator glanced at the screen. “Your BHP remains stable. That's good.”

Nora said nothing.

“Do you feel supported in your current transition to oncology?”

“Yes.”

The session ended in thirteen minutes. On her way out, she passed a wall display advertising Adaptive Recovery resources for employees managing loss-related disruption. A smiling couple in business-casual clothing stood in a sunlit kitchen beside the sentence FUNCTION IS A FORM OF HEALING.

Nora stopped walking for half a second. Not enough for anyone else to notice. Then she kept going.

That afternoon Amira called without scheduling first.

“I was re-reading the review notes from the second grant rejection,” she said after hello. “One of them used the phrase ‘limited clinical relevance’ about the imaging outcomes.”

Nora turned from her monitor toward the glass wall of her office. “Based on what?”

“Based on the fact that the existing treatment literature already established efficacy using functional measures.”

“The literature established efficacy on measures incapable of detecting the mechanism.”

“Yes,” Amira said. “That was not persuasive to the panel.”

Below them, in the courtyard, two employees crossed from Building C toward the café carrying the same Vantara-branded tote bag. They moved at matching speed.

Nora said, “If the framework excludes the variable, the variable becomes clinically irrelevant by definition.”

“Exactly.”

They were silent for a moment, connected by the kind of agreement that did not reduce isolation so much as make it shareable for the duration of a phone call.

Amira said, “There were clinicians who contacted me after the paper came out.”

“How many?”

“Three. Over two years. All privately. None willing to put concerns in writing.”

“Why?”

Another brief silence. Then Amira said, “Because they prescribe it.”

Nora understood. The system did not require active deception. It required enough people whose professional lives were built on the existing framework that doubt became self-indictment.

After the call, she opened a new section in her document.

Current evaluative instruments are structurally incapable of distinguishing therapeutic resolution from pharmacological suppression when both produce equivalent short-term functional outcomes.

She stopped after structurally incapable and rewrote the sentence twice. Not because the point was unclear to her. Because the precision mattered. If she made the sentence too broad, it could be dismissed as rhetoric. Too narrow, and it would fail to carry the architecture.

At 5:52, as she was packing her laptop, an email arrived from Martin Hale's assistant.

Martin would appreciate twenty minutes of your time tomorrow at 12:30, if available.

No subject line beyond Meeting Request. No explanation.

Nora read the message once, then again.

Martin had received her ISR submission. He had predicted the conclusion before the panel issued it. He occupied the level of the institution where concerns were translated into forms the institution could survive.

She replied that she was available.

That night she did not work on the document. She sat at the kitchen table instead, with the photograph on the counter and the apartment quiet around it.

At 9:14, she opened the drawer beside the refrigerator where she kept old family papers that had not found a better place. Utility bills from after the condo sale. A photocopy of her mother's living will. The funeral program, folded once. She took it out and placed it on the table.

White card stock. Black lettering. Service order. Two readings. Three speakers. Interment information below.

She knew all of this.

What she did not know was what her own body had done while these things were occurring.

She touched the edge of the paper with one finger and waited. Not for memory this time. For distress. For pressure. For the smallest sign that the program belonged to an event she had inhabited rather than administratively completed.

Nothing came.

The absence had begun to change. It no longer felt neutral. The data had given it contour, and contour had given it threat. Before, it had merely been how she was. Now it was evidence.

She put the program back in the drawer and closed it carefully.

The next day, at 12:26, she left her building and walked two blocks to the restaurant Martin had chosen. It was quiet, expensive in the restrained way meant for business lunches, with small tables and acoustics calibrated to make private conversations possible without implying secrecy. Martin was already there.

He stood when she approached. The gesture was old-fashioned enough to feel accidental.

“Dr. Chen,” he said.

“Martin.”

They sat. Water arrived. Menus were opened and closed almost immediately. Martin ordered a salad he appeared not to want. Nora ordered tea because it required no appetite.

For the first several minutes he asked ordinary questions in an ordinary voice. How was the oncology transition. Was the team making good use of her. Had she had a chance to read the ISR's final language carefully.

“Yes,” Nora said.

“And?”

“The methodology is compliant with the question the review was asked to answer.”

Martin's expression changed very slightly. “That's one way to put it.”

“It appears to be the most accurate.”

He folded his napkin once, then set it down beside the plate. “I read your submission.”

“I assumed you had.”

“It was thorough.”

Nora waited.

Martin said, “I want to be clear that I take methodological concerns seriously.”

“I know.”

“The problem,” he said, “is that your concern extends beyond methodology in any ordinary sense. You're identifying a possible gap in the evidentiary structure underlying the product's approval.”

“Yes.”

He looked at her for a moment that was not evaluative so much as calibrating. “That's a serious thing to identify.”

“It remains serious whether I identify it or not.”

A server brought their drinks. Martin thanked her. When she left, he said, “The trial design was FDA-approved. The post-market framework is compliant. The published efficacy literature remains broadly consistent. These things matter.”

“They do,” Nora said. “They are also not the same as being complete.”

Martin's fingers rested against the stem of his water glass. “There are proper channels for expanding a scientific debate.”

“I used the proper channels.”

A pause. Two seconds, perhaps three.

“Yes,” he said. “You did.”

Nora looked at him. The pause had not been large, but it had weight. Something had passed across his face, not emotion exactly but resistance meeting a surface it recognized.

He said, more carefully now, “The ISR is closed. It will remain closed. My advice, if you want it, is to pursue any broader argument through academic publication. Carefully. With discipline.”

“On my own time.”

“Yes.”

“With company approval.”

He did not answer at once.

“That's the policy,” he said.

Nora wrapped one hand around the warm teacup and let the heat sit there. “What if the methodology is compliant,” she asked, “and also wrong?”

Martin looked down at the tablecloth, then back at her. The expression was not irritation. It was something closer to fatigue.

“Then,” he said, “we address it through the appropriate channels.”

Nora thought of the questionnaire. The missing category. The trial footnote. The citation count. The soft blue sign in Employee Health telling her that function was a form of healing.

She said, “That answer contains its own problem.”

Martin did not disagree. He only said, “I know this is difficult.”

The sentence was sincere. It was also unusable.

Lunch concluded without conclusion. They returned to the office separately.

At 6:18, Nora drove to the cemetery.

The evening was cool enough for a jacket. The cemetery itself was orderly, professionally maintained, the grass cut short and the pathways edged with gravel that shifted underfoot without making much sound. She parked near the far row and walked the remaining distance carrying nothing.

LILING CHEN 1958–2029

The stone was clean. Ming must have come recently. Someone had left a small arrangement of white chrysanthemums in a low vase. Nora stood in front of the grave and read the name twice, then the dates.

She remained there for twenty minutes.

No tears came. No memories with weather attached to them. No pressure rose in her throat. She registered the coolness of the air, the faint smell of cut grass, the sound of a car on the road beyond the trees. She registered the stone, the chrysanthemums, her own shoes darkening slightly at the toes where the ground held moisture.

The grief did not arrive.

What arrived instead was fear.

Not dramatic fear. Not the fear of immediate danger. The colder kind that comes when an abstraction finishes becoming physical. She was standing at her mother's grave and the absence inside her was so complete, so clean, so technically successful, that it could no longer be interpreted as resilience.

She stayed another minute after understanding this, because leaving immediately would have looked too much like reaction, even though no one was there to see it.

Then she walked back to the car.

At home, she opened her document and added a line to the clinical implications section.

The suppression of grief-processing may present phenomenologically not as distress, but as an anomalous absence of affective access to loss-related memory.

She looked at phenomenologically for a long time before deciding not to replace it. It was the correct word. The sentence remained on the screen, technical and bloodless and exact.

On the counter behind the laptop, the photograph of Liling Chen watched nothing at all.

Nora wrote the next sentence anyway.